Is 2C-B (4-Bromo-2,5-dimethoxyphenethylamine) safe for babies and kids?
Severe risk for kidsInfants are more vulnerable to 2C-B (4-Bromo-2,5-dimethoxyphenethylamine) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What is 2c-b (4-bromo-2,5-dimethoxyphenethylamine)?
The IUPAC name is 2-(4-bromo-2,5-dimethoxyphenyl)ethanamine.
Also known as: 4-Bromo-2,5-dimethoxyphenethylamine, 66142-81-2, 2-(4-Bromo-2,5-dimethoxyphenyl)ethylamine, 2,5-Dimethoxy-4-bromophenethylamine.
- IUPAC name
- 2-(4-bromo-2,5-dimethoxyphenyl)ethanamine
- CAS number
- 66142-81-2
- Molecular formula
- C10H14BrNO2
- Molecular weight
- 260.13 g/mol
- SMILES
- COc1cc(CCN)c(OC)cc1Br
- PubChem CID
- 98527
Risk for babies
Severe riskInfants are more vulnerable to 2C-B (4-Bromo-2,5-dimethoxyphenethylamine) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
Neonates and infants up to 12 months have incomplete blood-brain barrier development, immature Phase I/II metabolic enzymes (particularly CYP3A4, UGT1A1), and higher gastrointestinal permeability. Equivalent doses produce higher internal concentrations and longer residence times.
Risk for pregnant and nursing people
Context-dependentPregnancy alters the metabolism and distribution of 2C-B (4-Bromo-2,5-dimethoxyphenethylamine), potentially increasing fetal exposure. The developing embryo/fetus is vulnerable during organogenesis (weeks 3-8) and neurological development. Placental transfer should be assumed.
No specific reproductive toxicity data identified, but pregnancy-specific safety data is limited for most chemicals. Precautionary minimization of exposure is recommended.
Regulatory consensus
2 regulatory and scientific bodies have classified 2C-B (4-Bromo-2,5-dimethoxyphenethylamine). The classifications differ — that's the data.
| Agency | Year | Classification | Notes |
|---|---|---|---|
| DEA | 1995 | Schedule I controlled substance | |
| UN | 2001 | 1971 Convention — Schedule II |
Regulators apply different standards of evidence — animal-data weighting, exposure-pattern assumptions, epidemiological power thresholds — which is why two scientific bodies can review the same data and reach different conclusions. The disagreement is the data.
Where kids encounter 2c-b (4-bromo-2,5-dimethoxyphenethylamine)
- Illicit Drug
- Research Chemical
Safer alternatives
Lower-risk approaches that achieve a similar outcome to 2C-B (4-Bromo-2,5-dimethoxyphenethylamine):
-
Psilocybin (in clinical/research context)
Trade-offs: Better-characterized safety profile. Longer history of use. Still Schedule I but FDA Breakthrough Therapy.Relative cost: N/A (not legally available)
Frequently asked questions
Is 2c-b (4-bromo-2,5-dimethoxyphenethylamine) safe for kids?
Infants are more vulnerable to 2C-B (4-Bromo-2,5-dimethoxyphenethylamine) than children or adults due to immature hepatic/renal clearance, higher intake-to-body-weight ratio, rapid organ development, and increased gastrointestinal absorption.
What should I do if my child is exposed to 2c-b (4-bromo-2,5-dimethoxyphenethylamine)?
Minimize infant exposure through source control. For breastfeeding mothers: reduce maternal exposure. For formula-fed infants: use certified low-migration bottles and verified water sources. Consult pediatrician regarding any concerns.
See 2C-B (4-Bromo-2,5-dimethoxyphenethylamine) in the baby app
Look up products containing 2c-b (4-bromo-2,5-dimethoxyphenethylamine), compare to alternatives, and explore the full data record.
Open in baby View raw API dataSources (1)
- —
Reference data, not professional advice. Aggregates publicly available regulatory and scientific data; not a substitute for veterinary, medical, legal, or regulatory advice. Why we built ALETHEIA →